2025 International Congress

October 5-9, 2025. Honolulu, Hawaii.

View by Title View Categories

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

LRRK2 Mutation in a Patient with NMDA and GAD 65 Antibodies

S. Ticehurst Corona, F. García Hernández (Mexico City, Mexico)
LRRK2 Pathway Inhibition By NEU-411, a Potent, Selective, CNS-Penetrant LRRK2 Inhibitor In Healthy Participants

C. Wong, S. Dheerendra, T. Dang, F. Nahab, J. Zheng, S. Savage, Z. Pei, C. Wynne, S. Jackson, L. Desnoyers (South San Francisco, USA)
LRRK2 Polymorphisms and Associations with Parkinson’s Disease in Participants of East Asian, Southeast Asian, and European Descent

S. Nguyen, R. Edillor, J. Ruiz-Tejeda, R. Rajmohan, N. Phielipp (Irvine, USA)
Lung Function and the Risk of Parkinson’s Disease: A Population-based Cohort Study

JY. Liu, SC. Wang, XT. Zheng, SR. Zhang, QR. Jiang, CY. Li, HF. Shang (Chengdu, Sichuan, China)
Lysosomal Lipid Dysregulation in Parkinson’s Disease: Genetic and Medication Effects in CSF Metabolomics

J. Suh, R. Maciuca, E. Macklin, S. Davis, J. Kluss, N. Xia, H. Yazd, M. Schwarzschild, S. Huntwork-Rodriguez (South San Francisco, USA)
Machine Learning Analysis of DTI-Derived Free Water Reveals Distinct Parkinson’s Disease Subtypes: A Two-Year Longitudinal Study

A. Vijayakumari, H. Fernandez, B. Walter (Cleveland, USA)
Machine Learning Model using Eye Movements for the Differential Diagnosis of iPD and Atypical Parkinsonian Syndromes

A. Sekar, D. Kaski (London, United Kingdom)
Machine-learning Prediction of Cognition in Parkinson’s disease: Benchmarking EEG Source Functional Connectivity and Structural MRI

A. Tetereva, G. Hall-Mcmaster, N. Slater, A. Harris, R. Shoorangiz, C. Le Heron, R. Keenan, I. Kirk, W. Meissner, T. Anderson, T. Melzer, J. Dalrymple-Alford, N. Pat (Christchurch, New Zealand)
Magnetic Resonance Guided Focused Ultrasound for Essential Tremor and Tremor dominant Parkinson’s Disease Case Series

M. Jayasree, M. Panigrahi, G. Gorrepati (Hyderabad, India)
Malnutrition Risk in Huntington’s Disease: A Cohort Study on Prevalence and Prognosis with Mendelian Randomization Validation

YF. Cheng, HF. Shang (Chengdu, Sichuan, China)

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z